NIL solutions from Ohio State’s Gene Smith and NCAA are a step backward
Ohio State athletic director Gene Smith should be in his Danny Glover “I’m too old for this” stage of his ...
Wednesday, May 7, 2025
Tag: Gene
What happens when a $2 million gene therapy is not enough By Reuters
5/5 © Reuters. Elizabeth Kutschke spends time at the park with her 2-year-old son, Ben, who was diagnosed with spinal ...
Revisiting the Three Biggest Gene Editing Stocks
The adage “rules are meant to be broken” doesn’t work well if you’re a disciplined investor. What’s the point of ...
Taysha Gene Therapies: Astellas Throws Lifeline For On Rett And GAN Programs (NASDAQ:TSHA)
Artur PlawgoShares of Taysha Gene Therapies (NASDAQ:TSHA) have fallen by 85% since the September 2020 IPO was priced at $20. ...
The Future Perfect 50: Target Malaria and the “gene drive” approach to eradicating malaria
This could very well be the last century in human history when people die from malaria. If and when we ...
Prime Medicine Stock: A Gene Editing IPO
Software quality assurance engineers know there’s no such thing as “defect free” software. It’s all about making a judgment call ...
Beam Therapeutics Inventory: A Chief in Gene Modifying Tech?
Don’t spend money on tales. Don’t spend money on an organization earlier than they've significant revenues. Don’t spend money on ...
A Full Record of 27 Gene Modifying Shares
Artificial biology is the one most fun know-how we all know of, however execution has been problematic. From Intrexon to ...
RECOMMENDED
Get the latest news and follow the coverage of Investing, World News, Stocks, Market Analysis, Business & Financial News, and more from the top trusted sources.